Linjing Zhu
- Hematology top 10%
- Platelet Disorders and Treatments 2
-
- SARS-CoV-2 and COVID-19 Research 3
- Viral Infections and Vectors 2
- Viral Infections and Outbreaks Research 2
-
- Virus-based gene therapy research 2
-
- Antiplatelet Therapy and Cardiovascular Diseases 2
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- vaccines and immunoinformatics approaches 1
- Partner nations
- ChinaSwedenUnited Kingdom
In The Last Decade
Linjing Zhu
10 papers receiving 372 citations
Peers
Comparison fields: 5 of 62
- Hematology 76
- Oncology 136
- Infectious Diseases 85
- Internal Medicine 16
- Immunology 73
Countries citing papers authored by Linjing Zhu
This map shows the geographic impact of Linjing Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linjing Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linjing Zhu more than expected).
Fields of papers citing papers by Linjing Zhu
This network shows the impact of papers produced by Linjing Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linjing Zhu. The network helps show where Linjing Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Linjing Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2022 | 11 | |
| 5 | 2021 | 99 | |
| 6 | 2021 | 61 | |
| 7 | 2021 | 2 | |
| 8 | 2020 | 38 | |
| 9 | 2019 | 0 | |
| 10 | 2014 | 10 | |
| 11 | 2011 | 147 |
About Linjing Zhu
Linjing Zhu is a scholar working on Infectious Diseases, Physiology and Hematology, having authored 11 papers that have together received 375 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Virus-based gene therapy research (2 papers), Viral Infections and Vectors (2 papers), Viral Infections and Outbreaks Research (2 papers), Platelet Disorders and Treatments (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Hematology (76 citations), Oncology (136 citations) and Infectious Diseases (85 citations). Linjing Zhu has collaborated with scholars based in China, Sweden and United Kingdom. Frequent co-authors include Xilin Wu, Bilian Huang, Waqas Nawaz, Shijie Xu, Zhiwei Wu, Hu Hu, Zhangsen Huang, Nailin Li, Lei Jiang and Gunnar Nilsson. Their work appears in journals such as Blood, Scientific Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.